Long-term follow up of pure myxoid liposarcomas with special reference to local recurrence and progression to round cell lesions

Pathology International

Volumn 49, Issue 8, 1999, Pages 710-715

  Fukuda, Toshiro ^a   Oshiro, Yumi ^b   Yamamoto, Ichiro ^b   Tsuneyoshi, Masazumi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Mixed liposarcoma; Myxoid liposarcoma; Prognosis; Recurrence; Round cell; Round cell liposarcoma; Survival rates

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MITOSIS; MYXOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOSARCOMA; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SOFT TISSUE NEOPLASMS; TIME FACTORS;

EID: 0032694173     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00941.x     Document Type: Article

References (16)

1. Le CT, Rouesse J, Contesso G et al. Liposarcoma in adults. Prognostic factors in a series of 84 cases. Nouv. Presse Med. 1981; 10: 3625-3628.
2. Chang HR, Hajdu SI, Collin C et al. The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer 1989; 64: 1514-1520.
3. Knight J, Renwick P, Cin P et al. Translocation t(12;16) (q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995; 55: 24-27.
4. Smith TA, Easley KA, Goldblum JR. Myxoid/round cell liposarcoma of the extremities: A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am. J. Surg. Pathol. 1996; 20: 171-180.
5. Kilpatrick SE, Doyon J, Choong PF et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996; 77: 1450-1458.
6. Enzinger F, Winslow D. Liposarcoma: A study of 103 cases. Virchows Arch. (Pathol. Anat.) 1962; 335: 367-388.
7. Mattison HR, Reichman RC, Benedetti J et al. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am. J. Med. 1988; 85: 20-25.
8. Conte RR, Kehoe WA, Nielson N et al. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am. J. Hosp. Pharm. 1986; 43: 2460-2464.
9. Enzinger FM, Weiss SW. Staging and grading of soft tissue sarcomas. In: Soft Tissue Tumors, 3rd edn. CV Mosby, St Louis, 1995; 6-12.
10. Hashimoto H, Daimaru Y, Takeshita S et al. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer 1992; 70: 2816-2822.
11. Tallini G, Akerman M, Dal CP et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group). Am. J. Surg. Pathol. 1996; 20: 1047-1055.
12. Aman P, Ron D, Mandahl N et al. Rearrangement the transcription factor gene CHOP in myxoid liposarcoma with t(12;16)(q13; p11). Genes Chromosomes Cancer 1992; 5: 278-285.
13. Fletcher C, Akerman M, Dal Cin P et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the chromosomes and morphology (CHAMP) collaborative study group. Am. J. Pathol. 1996; 148: 623-630.
14. Enzinger FM, Weiss SW, Liposarcoma. In: Soft Tissue Tumors, 3rd edn. CV Mosby, St Louis, 1995; 431-466.
15. Campbell DJ, Eckhauser FE, Oehler JR et al. Liposarcoma of the lower extremity. Surgery 1980; 88: 453-460.
16. Kuroda M, Ishida T, Takanashi M et al. Oncogenic transformation and inhibition of adipocytic conversion of pre-adipocytes by TLS/FUS-CHOP type II chimeric protein. Am. J. Pathol. 1997; 151: 735-744.